CA2057463C - Vitamin/mineral composition - Google Patents
Vitamin/mineral compositionInfo
- Publication number
- CA2057463C CA2057463C CA 2057463 CA2057463A CA2057463C CA 2057463 C CA2057463 C CA 2057463C CA 2057463 CA2057463 CA 2057463 CA 2057463 A CA2057463 A CA 2057463A CA 2057463 C CA2057463 C CA 2057463C
- Authority
- CA
- Canada
- Prior art keywords
- vitamin
- shilajit
- formula
- composition
- mineral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A composition comprising Shilajit or an extract thereof in a vitamin and/or mineral preparation. Shilajit is a compact mass of vegetable organic matter, composed of a gummy matrix interspersed with vegetable fibres and minerals. Substances which have been identified in Shilajit include moisture, gums, albuminoids, calcium, potassium, nitrogen, silica, resin, vegetable matter, magnesium, sulphur, iron, chloride, phosphorous, iodine, glycosides, tannic acid, benzoic acid and a number of vitamins and enzymes. The invention further relates to the use of Shilajit or an extract thereof in a vitamin and/or mineral preparation to enhance the energy properties of the preparation.
Description
RBP File No. 6061-OOB
S7~63 Title: VITAMIN/MTNRRAT. COMPOSITION
FI~LD OF THE INVENTION
The present invention relates to the use of Shilajit or extracts thereof in vitamin and/or mineral compositions; to vitamin and/or mineral compo~itions containing Shila~it or extracts thereof; and, to methods to restore energetic balance or intensity, or to support or enhance a bioenergetic field in a mammal using Shila~it or extracts thereof.
0 RA~K~.ROUND OF THE INVENTION
Over the past 50 years or so, scientists have become increasingly aware of biomagnetic energy which involves the electromagnetic energy generated by living cells, as well as subtle energetic fields, which interpenetrate and surround living organisms.(See for example Becker, R., and G. Sheldon, The Body Electric:
Electromagnetism and the Foundation of Life, New York.
William Morrow and Cl ~ny Inc., 1985; H.S. Burr and C.T.
Lane, in "Electrical Characteristics of Living Systems"
((1935) Yale Journal of Biology and Nedicine 8:31; H.S.
Burr and F.S. Northrop,"Evidence for the Existence of an Electrodynamic Field in Living Organisms" in Proceedings of the National Academy of Sciences of the U.S.A.
5:284;and,H.S. Burr, in "The Me~n;ng of Bio-Electric Potentials" ((1944) Yale Journal of Biology and Nedicine 16:353)-Vibrational medicine treats the human body byintegrating and b~lancing the energetic systems which influence cellular patterns of manifestation. The basis for vibrational medicine is the finding that a series of interactin~ subtle energy systems help regulate cellular physiology. According to the theory of vibrational medicine, a person's body tends to resonate with one ~ in~nt energetic vibration and, when weakened or shifted from equilibrium, the body tends to oscillate at a different and less harmonious frequency. These imbalances 2(~57~63 can lead to dysfunction, and the restoration of balance assists the organism to regain its normal functioning.
Anything which helps the body rebalance and/or restore the intensity of its energy can thu8 have a positive effect on health.
Acupuncture, acupressure, andelectroacupressure are examples of therapies which help to restore energetic balance. The techniques rely on influencing and balancing patterns of energy which express through meridians, or microtubular ch~nnels, which carry subtle energy to the various organs and tissues of the body. In the 1960's, Kim Bong Han discovered these microtubular chAnn~ls, ranging in diameter from 0.5 to 1.5 microns, using microautoradiography (S. Rose-Neil, "The Work of Professor Kim Bong Han", (1967) The Acupuncturist 1:15).
Other therapies which have been used to restore energetic balance and/or energetic intensity include magnetotherapy, ultrasonic therapy and homeopathy. Each of these techniques works by precipitating change in energy fields, which in turn stimulates change at the physical level. In homeopathy, a person ingests an extremely dilute solution of a substance, often so dilute that no molecules of the original substance ~F ~in. It appears that the energetic frequency of the substance, serves as the active part of the homeopathic remedy.
In the Eastern world, a compound known as Shilajit (silajit) has a history of use as a folk remedy for various disorders, including genito-urinary diseases, diabetes, gall stones, jaundice, enlarged spleen, fermentative dyspepsia, worms, digestive disorders, piles, epilepsy, nervous disorders, eczema, anaemia, anorexia, asthma etc. Shilajit has also been used as a tonic to help retain youthful vigour. Shilajit has been al' i n i stered either by itself or in combination with certain other ayurvedic (herbal) medicines.
Shilajit is a natural exudate ejected from rocks during hot weather in the lower Himalayas, Vindhya and 2~S7'~63 other mountain tracts and Nepal, or it may be a tar formed in the earth from the decomposition of vegetable substances. ~See the In~1~n Nateria Medica, page~ 23 to 32 for a detailed discussion of the compo~ition and properties of Shilajit). It is a compact ma~s of vegetable organic matter, composed of a gummy matrix interspersed with vegetable fibres and mineralq.
Substances which have been identified in Shilajit include moisture, gums, albuminoids, calcium, potassium, nitrogen, silica, resin, vegetable matter, magnesium, sulphur, iron, chloride, phosphorous, iodine, glycosides, tannic acid, and a A ~r of vitamins and enzymes. Shilajit also contains benzoic acid, a compound which, along with its derivatives, has been used as a component of nutritional vitamin and mineral preparations.
~RY OF THE INV~NTION
The present inventor has found that Shilajit over and above its nutritional and herbAl content has novel energetic properties. Measurement of subtle energy changes indicate that Shilajit has a vibratory field that is substantially stronger than any vitamin, mineral, food substance or herb. Its vibratory field is also stronger than the vibratory fields of any of the known ingredients which make up Shilajit, when these ingredients are tested as pure substances from non-Shilajit sources.
The present inventor has also surprisingly found that when a small amount of Shilajit is added to a vitamin or mineral preparation, the energetic properties of the vitamin or mineral preparation are enhAnced. In particular, the present inventor has found that the addition of a small amount of Shilajit to a vitamin or mineral preparation increases the energy field of the entire preparation to at or near the vibratory level of pure Shilajit.
The addition of Shilajit to vitamin or mineral preparations imparts to the preparations an energetic quality a~ove and beyond their nutritional content. As ;2C~S7~63 well, the energetic quality of Shilajit-fortified vitamin and mineral preparations support or enhAncc a user~s bioenergetic field.
The present invention therfore relates to the use of Shilajit or extracts thereof in a vitamin and/or mineral preparation to enhance the energy properties of the preparation.
The invention also relates to a composition comprising Shila;it or extracts thereof in a vitamin and/or mineral preparation.
The invention further relates to a method to restore energetic balance or intensity, or to support or enhance a bioenergetic field in a - ~l comprising administering to a - ~l an effective amount of Shilajit or extracts thereof. Preferably, the Shilajit or extract thereof is administered in a vitamin and/or mineral preparation.
BRIEF n~.~rRTPTION OF THE DRAWINGS
Further details of the invention are described below with the help of the examples illustrated in the accompanying drawings in which:
Figure 1 is a gragh showing the transmission of infrared light by the Original Formula vitamin- ;neral formulation;
Figure 2 is a gragh showing the transmission of infrared light by a sample containing the components of the Original Formula vitamin-mineral formulation and 13 mg of Shilajit;
Figure 3 is a gragh showing the transmission of infrared light by the Formula S.T.R. vitamin in~ral formulation;
Figure 4 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula S.T.R. vitamin-mineral formulation and 13 mg of Shilajit;
Figure 5 is a gragh showing the transmission of infrared light by a sample containing the components of ;~C~5~7~63 the Formula SnT~R~ vitamin-mineral formulation and 40 mg of Shilajit;
Figure 6 i9 a gragh showing the transmission of infrared light by the Formula SUPER C-M-K vitamin-mineral formulation;
Figure 7 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula SUPER C-M-K vitamin-mineral formulation and 13 mg of Shilajit;
Figure 8 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula SUPER C-M-K vitamin-mineral formulation and 40 mg of Shilajit;
Figure 9 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula C.N.R. vitamin-mineral formulation and by a sample containing the components of the Formula C.N.R.
vitamin-mineral formulation and 13 mg of Shilajit;
Figure 10 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula V.S.C. vitamin-mineral formulation and by a sample cont~; n i ng the components of the Formula V.S.C.
vitamin-mineral formulation and 13 mg of Shilajit;
Figure 11 are chromatograms of alcohol solutions of the components of the Formula S.T.R. vitamin- ineral formulation with (Figure llA~ and without ~Figure llB) Shilajit;
Figure 12 are chromatograms of alcohol solution~
of the components of the Original Formula vitamin-mineral formulation with (Figure 12A) and without (Figure 12B) Shilajit;
Figure 13 are chromatograms of alcohol solutions of the components of the Formula C.N.R. vitamin-mineral formulation with (Figure 13A) and without (Figure 13B) Shilajit;
- Figure 14 are chromatograms of alcohol solutions of the components of the Formula S~PER C-M-K vitamin-ZC'57~63 mineral formulation with (Figure 14A) and without(Figure l~B) Shilajit;
Figure 15 are chromatographs of alcohol solutionq of the c~ ents of the Formula V.S.C. vitamin-mineral formulation with (Figure 15A) and without(Figure 15B) Shilajit.
~R~TT.Rn ~SCRTPTION OF THE INVENTION
As hereinbefore mentioned, the present invention relates to the use of Shilajit or extracts thereof in a vitamin and/or mineral preparation to enhAn~e the energy properties of the preparation. The invention also relates to a composition comprising Shilajit or extracts thereof in a vitamin and/or mineral preparation.
The vitamin and/or mineral preparation used in the invention and composition of the invention may be any commonly used vitamin and/or mineral preparation. The ingredients of an exemplary cl- -nly used vitamin and/or mineral preparation are set forth in Table 1. It will be appreciated that a vitamin and/or mineral preparation which may be used in the present invention may not include all the ingredients set forth in Table 1 and ingredients other than those set forth in Table 1 may be included in the preparation. Preferably, the vitamin and/or mineral preparation has the components set forth in any one of Tables 2 to 6. The concentration of the vitamin and/or mineral c onents will depend on individual needs and on the desired effect. Concentrations of components which may be used in the vitamin and/or mineral preparation are set forth in Tables 2 to 6.
The Shilajit used in the invention and in the composition of the invention may be obt~ined as an exudate from rocks in the Himalayas. The Shilajit may be obt~ined commercially, for example, from Dabur India Limited, New Delhi, India. The Shilajit may have the constituents set out in Table 7. Extracts of Shilajit may also be used in the present invention. Preferably, the Shilajit used in the invention is the Shilajit known as "Iron Shilajit~.
ZC'57/~63 Iron Shilajit is obtained by extracting raw Shilajit with purified water from the rocks from which it s~udes. The extracted Shila~it is then treated with a mixture of three herbs known as trifla, which include~ amla (emblica officinaliQ), bahera (ts i~Alia chebula), and haritaki (terminalia belerica), to L.- ve possible contaminants.
The purified Shila~it which is obtained i9 then dehydrated to l- -ve moisture. The Shila~it produced and refined by thiQ method is almost totally sterile. Laboratory analysis reveals that it has a bacterial count of only 50 colonies per gram and a yeast/fungus count of only 10 colonies per gram.
It will be appreciated that substances which have the energetic properties of Shilajit may also be used in the present invention. Such substances may be identified using the methods described in the examples herein. For example, a substance which has the energetic properties of Shila;it may be identified by dete ining the degree of oscillation of the substance using a Cameron Aurameter (See Example 1).
The concentration of Shilajit in the composition of the invention will depend on individual needs and on the desired effect. The concentration of the Shilajit in the composition of the invention may be from about 0.4% to 10%, preferably about 1% to 3%, most preferably 1% to 2%
by weight of the composition.
In a preferred embodiment of the invention, the c~ osition of the invention includes but is not limited to the c~ -~nts set out in Table 4 herein with 1% to 2%
by weight of Shila;it.
The composition of the invention may be prepared by ixing the various components of the composition using conventional methods. In particular, the various components of the composition of the invention may be mixed in powder form and/or encapsulated and/or pressed into solid form preparations such as tablets or pills.
The preferred composition of the invention may be prepared 2~57~63 according to the constituent ranges set forth herein in Table 1.
The invention also relate8 to ~nhAnced embodiments of the composition of the invention which include the composition described above contAini~g other additives. Examples of such additives are flavoring and coloring agents, lipotropic factors, amino acids, glAndlllar concentrates, bioflavanoids, phospholipids, para amino benzoic acid, sorbitol, betaine hydrochloride, N-N-dimethylglycine, herbs, pectin, cellulose, di-calcium phosphate, silica gel, stearic acid and magnesium - stearate.
The compositions of the invention are intende~
for A~' inistration to l- -n~ or Ani -ls.
The present invention also contemplates a method to restore energetic ~AlAnce or intensity, or to support or ~nhAn~e a bioenergetic field in a mammal comprising administering to a - -l an effective amount of Shilajit.
Preferably the method is carried out through the use of the composition described above. The method of the invention may be used to restore energy balance or energy intensity or to support or enhance a bioenergetic field in a - -l particularly in cases where there has beèn energy dysfunction as a result of disease or trauma. The compositions of the invention may be pa_ticularly useful in conditions such as artherosclerosis, heart disease, physiological stress, hypoglycemia, adrenal weAkness, arthritis, candidiasis, cancer, p~- -n~trual syndrome, menopause, prostatitis, bacterial and viral infections, heavy metal accumulations, nicotine addiction, hypertension, muscle cramping, osteoporosis, hypothyroidism, nervous tension, anaemia and cataracts.
The following non-limiting examples are illustrative of the present invention:
EXAMPL~S
r le l The energetic properties of Shilaiit-cont~ining g Z~57~63 vitamin/mineral compounds were measured using a Cameron Aurameter. The instrument is a dowsing device developed by the Life Underst~n~lng Foundation of Santa pArhAra~
California. It consists of a metallic, weighted, spring-mounted pendulum connected to a handle by means of avertically hinged mount. The unique mount enables the pendulum to oscillate either vertically or horizontally in a free-floating fashion.
The Cameron Aurameter i8 sensitive to subtle energy fields given off by both animate and in~ni -te objects. The instrument is operated as follows. The aurometer is held so that the pendulum is at complete rest. The device is then moved over the object to be tested. If sufficient energy is being given off by the object, the pendulum oscillates. The amplitude of the oscillation is directly proportional to the intensity of energy. In other words, the greater the distance taken by the pendulum in completing its stroke, the stronger the energy emanating from the object.
Five vitamin in~ral formulations distributed by Creative Nutrition CanA~ Corp. Uxbridge, Ontario, under the trade mark VITAMOST~ were tested using the above described method: FORM~ V.S.C. (Table 2), FORMULA
S.T.R. (Table 3), ORIGINAL FORMULA (Table 4), FORMULA
C.N.R. (Table 5) and S~PER C-M-K (Table 6). The composition of these vitamin-mineral formulations are - shown in Tables 2 - 6, as indicated. For each of the products, tablets with the same manufacturing lot n ~er were taken, and ground into a powder. The powders were divided into three batches and varying predeterr;ned amounts of purified Shilajit powder ( 13 mg, 40 mg or 100 mg of Shilajit (Dabur India Limited, New Delhi, India) per tablet) were added to each batch. The powders were then repressed into tablets, in such a way that each retaine~
all of its original i~gredients in the same quantities plus 13 mg of Shilajit, 40 mg of Shilajit, or 100 mg of Shilajit per tablet. As controls, samples of each formula, - lo- 2~57~63 from the same manufacturing lot number as thosc ground and mixed with Shilajit, were retained and re-tabletted.
Thus, four samples of each fo_ IAtion were obtained for testing purposes, each sample containing identical amounts of the same active ingredients ~vitamin~ and minerals), with the exception that one sample contained no Shilajit;
the second sample contained 13 mg per tablet of Shllajlt;
the third sample contained 40 mg per tablet of Shilajit;
and the fourth sample contained 100 mg per tablet of Shilajit.
The results of testing of each of the four samples of the five formulations with the Cameron Aurometer are shown in Table 8.
As shown in Table 8, the addition of small amounts of purified Shila;it powder to vitamin inpra tablets enhances the energetic properties of the tablets.
It was also found that 10 grams of purified Shilajit powder caused the Aurometer to oscillate with an amplitude of 5 centimetres. Thus, the evidence suggests that the energy field of any combined vitamin-mineral-Shilajit tablet is stronger than either (a) the energy field of the equivalent vitamin-mineral tablet without Shilajit, or (b) the energy field of Shilajit itself.
Fxample 2 The energetic response of subjects to Shilajit-cont~inin~ compounds was measured using a Colight Body Ratio Analyzing Instrument, supplied by the Electro-Nedica Office, Rexdale, Ontario. The instrument is an electronic resonance device which measures subtle energetic frequency characteristics of the human body. It consists of a series of potentiometers connected to the subject by means of a galvanic plate held against the skin.
In particular, the energetic response of five healthy subjects to each of the five different formulations shown in Tables 2 - 6 was measured. The subjects chosen were as follows: #l - Male, aged 47; #2 -Female, aged 47; #3 - Male, aged 37; #4 -Nale, aged 54;and 2C~57~63 #5 - Male, aged 25. The subjects were a ln~stered the four samples (contAining no Shilajit, 13 mg, 40 mg, or 100 mg of Shilajit per tablet) of each of the five formulations as described in Example 1. Each set of tablets was enclosed in a thin, opaque paper envelope, blinded from both the subject and the Colight operator.
Although the Colight -chine is capable of measuring the electronic resonance of many bodily cells, organs and systems, only the vitality of each subject being tested was measured. Vitality is an indication of the strength of biomagnetic energy expressed throughout the entire body. The vitality ratio for each subject was recorded at baseline, i.e. prior to ~t inistration of the samples. Each of the four samples of the five fo lAtions were then placed against the skin of the -subject and the vitality ratio of the subject was recorded for each of the twenty different samples. This allowed a ; measurement of how the energy field of the subject would respond to the energy field of the various tablets.
The results are shown in Table 9. The vitality ratio, as measured by the Colight instrument, has a no -l rang~ of from 60 to 85, according to literature published by the Electro Medica Office. The results in Table 9 sho~w that the various samples of the vitamin- ineral formulations without Shilajit increased the vitality re~ings of the subjects, on average, by 2.0~. In every case, the samples of the vitamin-mineral formulations with Shilajit increased the vitality reading of each subject beyond that of the vitality readings of the same sample fo l~tions without Shilajit. Finally, the various samples of vitamin in~ral formulations with Shilajit increased the vitality readings of the subje_ts, on average, by 10.6%.
The vitality or strength of biomagnetic energy of the tablets themselves without reference to the energy field of any person was also measured using the Colight Body Ratio Analyzing Instrument and the results are shown 2~57~63 in Table 10. As shown in Table 10 no detectable vitality was measured by this method in any of the vitamin- ineral formulations that do not contain Shilajit. Adding Shilajit to these formulations gives them a vit21ity reading at or near that of pure Shilajit itself. The vitality reAd~ngs of the enhanced formulations are approximately the -~ame, regardless of how much Shilajit is added to each formulation.
r le 3 The refractive index of Shilajit-cont~in;ng preparations was measured using an Abbé Refractometer, Type I, manufactured by Atago. The refractive index of a substance is the ratio of the velocity of light in air to the velocity of light in the substance. All measurements were taken at 24 degrees Celsius. At this temperature, the refractive index for water is 1.3326 and 1.3624 for alcohol.
The purpose of this test was to dete inP
whether Shilajit improved the ability of an alcohol solution of a vitamin-mineral composition to transmit light. The refractive index of an alcohol solution of each of the five formulations set out in Tables 2 to 6 without Shilajit was measured, and compared with the refractive index of alcohol solutions of FORMULA C.N.R.
(Table 5) with 13 mg of Shilajit; FORMULA V.S.C. (Table 2) with 40 mg of Shilajit; SUPER C-N-K (Table ~) with 40 mg of Shilajit; FORNULA S.T.R. (Table 3) with 40 mg of Shilajit; and, ORIGINAL FORMULA (Table 4) with 40 mg of Shila;it.
To prepare the alcohol solutions ten tablets of each of the formulations to be tested were crushed and two grams of each of the resultant powders were taken and extracted with isopropyl alcohol to make a 10~ solution.
The results are shown in Table 11. In every case, Shilajit lowered the refractive index of the vitamin-mineral formulation. In other words, the addition of Shilajit improved the ability of the alcohol solution 2C~S~7~;3 of each of the vitamin-mineral formulation~ to tran~mit light.
Example 4 The effect of Shilajit on the transmi~sion of infrared light by a vitamin-mineral formulation was measured using an Infrared Spectrophotometer. This instrument produces a visual graph of varying percentages of transmission at different wave lengths of infrared light.
Ten percent alcohol solutions of each of the formulations to be tested were prepared as described in Example 3 and their ability to transmit infrared light was measured using a Perkin-Elmer 1310 Infrared spectrophotome~er. The results are shown in Figures 1 to 10. Because the machine may start at a different setting for each printout, the graphs are a relative or comparative form of measurement, rather than an absolute one. Therefore, when comparing the graphs for two different samples of the same formula, the shape of the curves is significant but the absolute measurement on the left-hand scale is not. For the same reason, the absolute numbers on the left-hand scale are not significant when comparing two readings on different curves, whereas the difference between two readings on the same curve are significant.
In comparing the graphs for the ORIGINAL
FORMULA, more peaks reached far higher for the formulation containing 13 mg of Shilajit per tablet (Figure 2) than for the one with no Shilajit (Figure 1). The latter curve (Figure 1) is very flat, with low plateaus rather than peaks. Similar relationships were found when comparing S.T.R. with 13 (Figure 4) and 40 mg (Figure 5) of Shilajit, whose curves show very high peaks, to S.T.R.
without Shilajit (Figure 3), which is very flat with low plateaus.
The curves for SUPER C.M.K. with 40 (Figure 7) and 13 mg (Figure 8) of Shilajit are almost identical~
2(!St~63 with high peaks, in the range of 4,000 to 1,600 cm~1, compared to the curve for SUPER C.M.K. without Shilajit (Figure 6) over the same range, which i8 almost completely flat.
Samples of Formula C.N.R. with and without Shilajit and samples of Formula V.S.C. with and without Shilajit were run simultaneously. The results of the C.N.R. without Shilajit and with 13 mg of Shilajit are shown in Figure 9 and the results of the V.S.C. without Shilajit and with 13 mg of Shilajit are shown in Figure 10. In both cases, the samples of the formulations with 13 mg of Shilajit were found to transmit about 10% more infrared light over the range of 3500 to 2700 cm~1 when compared to the samples without Shilajit, and approximately 2~ more in the ranges from 2700 to 2300 cm~
and from 1150 to 1000 cm~1.
The results indicate that the addition of Shilajit to otherwise identical vitamin-mineral formulations was found to improve the ability of these formulations to transmit infrared light.
Example 5 Paper chromatography was used to analyze samples of the vitamin/mineral formulations set out in Tables 1 to 5 with or without Shilajit. Paper chromatography is a qualitative method used for separating and identifying mixtures of substances, including vitamins and food products. The method i5 useful for discerning subtle differences in vitamins and food samples produced by different processing methods or from different soil conditions -- differences which are not detectable by quantitative assay.
The method described in Pfeiffer, E.E.
Chromatography Applied to Quality Testing, Wyoming:
Biodynamic Literature, 1984 was used to analyze samples of the vitamin/mineral formulations set out in Tables 2 to 6 with or without Shilajit. The method generally involves preparing a filter disk with a 0.1% silver nitrate ~c\s~
_ 15 -solution, and impregnating the prepared disk with a liquid extract of the test sample in a 0.1~ sodium hydroxide solution. This method results in the formation of various colour zones and patterns which reflect certaln aspects of sample quality.
Nuch work has been done with paper chromatography in comparing synthetic vitamins to natural source vitamins, and in comparing organic produce to that produced by conventional agricultural methods. (Pfeiffer, Ibid.) In both of these kinds of comparisons, the natural/organic versions display colours and patterns which are more distinct, deeper and more vibrant than their synthetic or conventional counterparts. Also, there are more pronounced boundaries and more clearly de~ined radial spokes in the natural/organic substances.
Chromatograms of samples containing each of Formula STR, ORGINAL, CNR, CMK and VSC without Shilajit and with Shilajit are shown in Figures 11 to 15. As shown in Figures 11 to 15 the samples with Shilajit (Figures llA, 12A, 13A, 14A and 15A) produce colour images which are more vibrant, more distinct, and with more clearly defined borders and more obvious radial spokes than the samples without Shilajit (Figures llB, 12B, 13B, 14B and 15B). These qualitative differences suggest an enh~n~ed energy quality for the samples with Shilajit compared to those without.
In particular, the presence of the vitamins and minerals in Formula S.T.R. give the paper disk its characteristic colours of reddish-brown, green, yellow and brown (going from the centre to the perimeter) (Figure llB). In the enh~nced Shila~it version, however, the rings of colour are deeper, more clearly defined and more vibrant (Figure llA). There is an extra ring of a deep blue (almost cobalt blue) in the Shilajit enh~nced formula that is not in the STR without Shilajit. The outside brown border is wider in the Shilajit version.
There is also an obvious spoke pattern interspersed with - 16 - ~C's~63 glimpses of the very light yellow (almost white) colour that does not appear in the STR without Shilajit.
The Shilajit enhanced verslon of the Original formula (Figure 12A) di4plays a distinct pattern of colours, spokes and rings that are quite different from the version without Shilajit (Figure 12B).
The differences between the two samples of the C.N.R. formula are more subtle, but they exist nevertheless. The outermost brown border is darker and more distinct for the version with Shilajit (Figure 13A).
There is a thin, brown ring about one quarter inch inside the perimeter in the version with Shilajit which is not apparent in the version without Shilajit (Figure 13B).
~ Also, the green colour and its fine spoke pattern is more - 15 distinct in the version with Shilajit.
The colour of the original paper disk for the Super C-M-K without Shilajit is a whitish gray (Figure 14B). This is so because the only active ingredients in this formula are calcium, magnesium and potassium. There are no vitamins present that would contribute the spectrum of colours visible in the other formulations. The ~nh~nced C-M-K with Shilajit, however, has a more distinct yellow perimeter than the C-M-R
without Shilajit (Figure 14A). The enh~nced Shilajit sample also has an obvious and distinct brown border (inside the outer yellowish one) which is almost totally lacking in the sample without Shilajit. The centre of the Shilajit enhanced sample contains a bluish-brown stain that is several times larger and many times more distinct than a very faint hint of such a stain in the sample without Shilajit.
The boarders of the colours in the Shilajit enh~nced sample of the V.S.C. formula are more clear and distinct (Figure 15A) than in the version without Shilajit (Figure 15B). In this latter version, the colours saem to wander or spill over from one ring to the next.
- 17 - 2C'5~7~63 TABL~ 1 Each Tablet contains Vitamin A . . . . . . . . . . . . 500 to 10,000 I.U.
Beta Carotene . . . . . . . . . 2,000 to 15,000 I.U.
Vitamin D . . . . . . . . . . . . . . 50 to 400 I.U.
Vitamin E . . . . . . . . . . . . . . 30 to 400 I.U.
Vitamin C . . . . . . . . . . . . . . 75 to l,000 mg Vitamin B-l . . . . . . . . . . . . . . . 2 to 80 mg Vitamin B-2 . . . . . . . . . . . . . . . 1 to 80 mg Niacin . . . . . . . . . . . . . . . . . 4 to 100 mg Niacinamide . . . . . . . . . . . . . . . 2 to 100 mg Pantothenic Acid . . . . . . . . . . . . 10 to 500 mg Vitamin B-6 . . . . . . . . . . . . . . 3 to 100 mg Folic Acid . . . . . . . . . . . . . 0.002 to 1 mg 15 Vitamin B-12 . . . . . . . . . . . . 3 to l,000 mcg Biotin . . . . . . . . . . . . . . . . . 3 to 80 mcg Calcium . . . . . . . . . . . . . . . . . 40 to 200 mg Nagnesium . . . . . . . . . . . . . . . 30 to 200 mg Potassium . . . . . . . . . . . . . . . 10 to 200 mg Iron . . . . . . . . . . . . . . . . . . 1 to 25 mg Iodine . . . . . . . . . . . . . . . 0.02 to 0.5 mg Manganese . . . . . . . . . . . . . . . . 0.8 to 6 mg Zinc . . . . . . . . . . . . . . . . . 1.5 to 30 mg Chromium . . . . . . . . . . . . . . . 10 to 80 mcg Selenium . . . . . . . . . . . . . . . 20 to 50 mcg 2C~57~63 VITAMOST~ Fr l~ V.S.C.
Vitamins Each Tablet contains 5 Vitamin A (fish liver oil) . . . . . . . 2,000 I.U.
Beta Carotene (pro-vitamin A) . . . . 6,000 I.U.
Vitamin E 'd-alpha tocopheryl succ.) . . . . 60 I.U.
Vitamin C calcium ascorbate) . . . . . . . . 150 mg Vitamin C ascorbic acid) . . . . . . . . . . 350 mg Vitamin B-_ (th;~ ine hydrochloride) . . . . . . 2 mg Vitamin B-2 (riboflavin) . . . . . . . . . . . . 1 mg Vitamin B-6 (pyridoxine hydrochloride) . . . . . 3 mg Vitamin B-12 (cobalamin) . . . . . . . . . . . 3 mcg Niacin ............................................ 4 mg 15 Niacinamide ....................................... 2 mg Pantothenic Acid (d-calc. pantothen.) . . . . . . 2 mg Folic Acid . . . . . . . . . . . . . . . . . 0.03 mg Biotin ............................................ 3 mcg LipoLlv~ic Factors Choline (bitartrate) . . . . . . . . . . . . . 40 mg Inositol .......................................... 10 mg dl-Methionine . . . . . . . . . . . . . . . . . 100 mg Minerals Magnesium toxide) . . . . . . . . . . . . . . . 30 mg 25 Potassium (citrate~ . . . . . . . . . . . . . . 10 mg Manganese (gluconate) . . . . . . . . . . . . . 1 mg Zinc (gluconate) . . . . . . . . . . . . . . . 1.5 mg Chromium (proteinate) . . . . . . . . . . . . . 20 mcg Selenium (proteinate) . . . . . . . . . . . . . 20 mcg 30 ~~ Medicinal Ingredients Betaine Hydrochloride . . . . . . . . . . . . . 12 mg Lemon Bioflavanoids . . . . . . . . . . . . . . 15 mg 1-Cysteine Hydrochloride . . . . . . . . . . . 75 mg Lecithin . . . . . . . . . . . . . . . . . . . 10 mg 35 ihy ~ concentrate ................................. 3 mg Spleen concentrate ................................ 3 mg Adrenal concentrate ............................... 3 mg ;~C'~i~7~i3 TAHL~ 3 VITANOSTo Fn 1 A S.T.R.
Vitamins Each Tablet contains Vitamin A 'fish liver oil) . . . . . . . . 2,500 I.U.
Vitamin D fish liver oil) . . . . . . . . . 100 I.U.
Vitamin E d-alpha tocopheryl succinate) . . 40 I.U.
Vitamin C ascorbic acid) . . . . . . . . . . . 200 mg Vitamin B-_ ( t,h;, ine hydrochloride ? . . . . . . 5 mg Vitamin B-2 (riboflavin) . . . . . . . . . . . . 5 mg 10 Vitamin B-6 (pyridoxine hydrochloride) . . . . 10 mg Vitamin B-12 (cobalamin) . . . . . . . . . . . 50 mcg Niacinamide .......................................... 5 mg Pantothenic Acid (d-calcium pantothenate) . . . 150 mg Folic Acid . . . . . . . . . . . . . . . . . 0.04 mg 15 Biotin . . . . . . . . . . . . . . . . . . . . 10 mcg Li~o~o~ic Factors Choline (bitartrate) . . . . . . . . . . . . . 10 mg Inositol . . . . . . . . . . . . . . . . . . . 10 mg Minerals 20 Calcium (carbonate) . . . . . . . . . . . . . . 50 mg Magnesium (oxide) . . . . . . . . . . . . . . . 35 mg Potassium (chloride) . . . . . . . . . . . . . 40 mg Iron (ferrous fumarate) . . . . . . . . . . . . 1.5 mg Iodine (potassium iodide) . . . . . . . . . 0.0225 mg Manganese (gluconate) . . . . . . . . . . . . . . 2 mg Zinc (gluconate) . . . . . . . . . . . . . . . 1.5 mg Chromium (proteinate) . . . . . . . . . . . . . 20 mcg Selenium (proteinate) . . . . . . . . . . . . . 20 mcg ~on-Medicinal Ingredients Para Amino Benzoic Acid (P.A.B.A) . . . . . . . . 5 mg B0taine Hydrochloride . . . . . . . . . . . . . 15 mg Lemon Bioflavanoids . . . . . . . . . . . . . . 20 mg Adrenal concentrate . . . . . . . . . . . . . . 10 mg 2~5~f~63 TABL~ 4 VITANOST~ Original F~ 1 A
Vitamins Each Tablet contains Vitamin A 'fish liver oil) . . . . . . . . 4,167 I.U.
Vitamin D fish liver oil) . . . . . . . . . 167 I.U.
Vitamin E d-alpha tocopheryl succinate) . 66.7 I.U.
Vitamin C ascorbic acid) . . . . . . . . . . . 200 mg Vitamin B- (thi~ ine hydrochloride) . . . . . 10 mg Vitamin B-2 (riboflavin) . . . . . . . . . . . 10 mg Vitamin B-6 (pyridoxine hydrochloride) . . . . . 10 mg Vitamin B-12 (cobalamin) . . . . . . . . . . 16.7 mcg Niacin~ i~e . . . . . . . . . . . . . . . . . . 10 mg Pantothenic Acid (d-calcium pantothenate) . . . 20 mg Folic Acid . . . . . . . . . . . . . . . . . 0.067 mg Biotin . . . . . . . . . . . . . . . . . . . 16.7 mcg Li~oLl~ic Factors Choline (bitartrate) . . . . . . . . . . . . . 10 mg Inositol . . . . . . . . . . . . . . . . . . . 10 mg Minerals Calcium (carbonate) . . . . . . . . . . . . . . 167 mg Magnesium (oxide) . . . . . . . . . . . . . . 66.7 mg Potassium (chloride) . . . . . . . . . . . . 16.5 mg Iron (ferrous fumarate) . . . . . . . . . . . . . 3 mg Iodine (potassium iodide) . . . . . . . . . . 0.038 mg Manganese (gluconate) . . . . . . . . . . . . . . 3 mg Zinc (glucona~e) . . . . . . . . . . . . . . . . 3 mg Chromium (proteinate) . . . . . . . . . . . . 33.3 mcg Selenium (proteinate) . . . . . . . . . . . . . 25 mcg ~ F A i C i n~ 1 Ingredients Para Amino Benzoic Acid (P.A.B.A) . . . . . . . 10 mg Betaine Hydrochloride . . . . . . . . . . . . . 20 mg Lemon Bioflavanoids . . . . . . . . . . . . . . 20 mg - 21 - 2C'5'7~3 VITAMOST~ F~ 1~ C.N.R.
Vitamins Each Tablet contains Beta Carotene (pro-vitamin A) . . . . . . 15,000 I.U.
Vitamin C (calcium ascorbate) . . . . . . . . . 835 mg Lipotropic Factors dl-Methionine ................................ 5 mg Nineral Selenium (proteinate) . . . . . . . . . . . . . 25 mcg 0 T-~ ~ FAiCin~1 Ingredients Glutathione . . . . . . . . . . . . . . . . . . 1.3 mg N,N-Dimethylglycine . . . . . . . . . . . . . . . 8 mg In a non-medicinal base containing Echinacea, Red Clover, Liver concentrate, Thymus concentrate, Damiana, Burdock, Marshmallow, Spleen concentrate, Elecampagne and Buckthorn.
The product contains no sugar, no starch, no colourings, no flavourings, no preservatives, no milk, no wheat, no corn, no gluten, no soy, no yeast.
- 22 - ~C'57~63 VITAMOST~ Super C-M-R
Vitamins Each Tablet contains Calcium (carbonate) . . . . . . . . . . . . . . 200 mg Nagnesium (oxide) . . . . . . . . . . . . . . . 200 mg Potassium (chloride) . . . . . . . . . . . . . 200 mg The product contains no sugar, no starch, no colourings, no flavourings, no preservatives, no milk, no gluten, no corn, no soy, and no yeast.
- 23 - ;~C'57~63 C _ nition of Shila~it~
~ - L
Organic (per cent) Benzoic acid 28 58 Hippuric acid 6.13 Fatty acids 2.36 Resin and waxy matter 7 32 10 Gums 1 .
Albuminoids 16.12 Vegetable matter, sand, etc. 2.15 Minerals**
Loss on ignition 5182.33 Silica (residue insoluble in HCl)2 69 Iron (Fe2~3) 0.64 Alumina (Al2O3) 2.61 Lime (CaO) 4.82 20 Magnesia (MgO) 1.20 - Sulphuric acid (S03) 0 97 Chloride (NaCl) oo 524 Phosphoric acid (P2O5) 25 Nitrogen 3.36 * From the Indian Nateria Nedica, pages 25 and 26.
**Mineral constituents obtained from the ash by incineration of the substance at a dull red heat.
- 24 - Z~57~63 Shila~it/ No. oi Au~ -Ler P O~U1 L Tablet Tablets Stroke SUPER C-M-K 0 4 3 cm 5 SUPER C-M-K 13 mg 4 7 cm SUPER C-M-K 40 mg 4 7 cm SUPER C-M-K 100 mg 4 7 cm FORMULA C.N.R. 0 12 3 cm FORNULA C.N.R. 13 mg 12 6 cm 10 FORMULA C.N.R. 40 mg 12 6 cm FORMULA C.N.R. 100 12 6 cm ORIGINAL FORMULA 0 6 3 cm ORIGINAL FORMULA 13 mg 6 7 cm ORIGINAL FORNULA 40 mg 6 7 cm 15 ORIGINAL FORMULA 100 mg 6 6 cm FORNULA S.T.R. 0 10 4 cm FORMULA S.T.R. 13 mg 10 6 cm FORMULA S.T.R. 40 mg 10 6 cm FORMULA S.T.R. 100 mg 10 6 cm 20 FORMULA V.S.C. 0 10 4 cm FORMULA V.S.C. 13 mg 10 7 cm FORMULA V.S.C. 40 mg 10 8 cm FORMUhA V.S.C. 100 mg 10 7 cm - 25 - 2C'57~;3 Subiect ~ t4 Baseline 63 66 72 80 74 Formula V.S.C. without Shilajit 67 68 73 82 75 Formula V.S.C. with 13 mg Shilajit 77 81 78 86 77 Formula V.S.C. with 40 mq Shilajit 81 81 82 86 77 Formula V.S.C. with 100 mg Shilajit 73 74 79 83 80 Baseline 63 66 72 80 74 10 Formula S.T.R. without Shilajit 65 69 73 80 75 Formula S.T.R. with 13 mg Shilajit 80 75 76 81 76 Formula S.T.R. with 40 mg Shilajit 73 83 85 81 77 Formula S.T.R. with 100 mg Shilajit 78 74 75 84 81 Baseline 63 66 72 80 74 15 Original Formula without Shilajit 64 67 73 81 74 Originial Formula with 13 mg Shilajit 71 72 74 87 79 Originial Formula with 40 mg Shilajit 71 80 78 84 79 Originial Formula with 100 mg Shilajit 72 77 75 90 78 Baseline 63 66 72 80 74 20 Formula C.N.R. without Shilajit 64 68 78 80 74 Formula C.N.R. with 13 mg Shilajit 75 75 85 82 77 Formula C.N.R. with 40 mg Shilajit 81 78 85 84 81 Formula C.N.R. with 100 mg Shilajit 71 77 83 81 78 Baseline 63 66 72 80 74 25 Super C-M-X without Shilajit 63 69 72 82 75 Super C-M-K with 13 mg Shilajit 72 75 79 84 77 Super C-M-K with 40 mg Shilajit 72 74 78 83 77 Super C-M-K with 100 mg Shilajit 66 72 84 84 78 - 26 - 2C~S7~6~
Vitalit~
R~Ar1; r~"~
Pure Shilajit 41 5 Formula VSC without Shilajit 0 Formula VSC with 13 mg Shilajit 41 Formula VSC with 40 mg Shilajit 43 Formula VSC with 100 mg Shilajit 41 Formula STR without Shilajit 0 10 Formula STR with 13 mg Shilajit 42 Formula STR with 40 mg Shilajit 42 Formula STR with 100 mg Shilajit 41 Original Formula without Shilajit 0 Original Formula with 13 mg Shilajit41 15 Original Formula with 40 mg Shilajit 37 Original Formula with 100 mg Shilajit41 Formula CNR without Shilajit 0 Formula CNR with 13 mg Shilajit 42 Formula CNR with 40 mg Shilajit 42 20 Formula CNR with 100 mg Shilajit 38 Super C-N-K without Shilajit 0 Super C-M-K with 13 mg Shilajit 41 Super C-N-K with 40 mg Shilajit 40 Super C-M-K with 100 mg Shilajit 40 - 27 - ;~C~S7~6~
Reiractive FORMULA C.N.R. with no Shilajit 1.3690 FORMULA C.N.R. with 13 mg of Shilajit 1.3682 FORMULA V.S.C. with no Shilajit 1.3841 FORMULA V.S.C. with 40 mg of Shilajit 1.3680 SUPER C-N-K with no Shilajit 1.3634 SUPER C-M-K with 40 mg of Shilajit 1.3624 10 FORMULA S.T.R. with no Shilajit 1.3654 FORMULA S.T.R. with 40 mg of Shilajit 1.3644 ORIGINAL FORMULA with no Shilajit 1.3664 ORIGINAL FORMULA with 40 mg of Shilajit 1.3650
S7~63 Title: VITAMIN/MTNRRAT. COMPOSITION
FI~LD OF THE INVENTION
The present invention relates to the use of Shilajit or extracts thereof in vitamin and/or mineral compositions; to vitamin and/or mineral compo~itions containing Shila~it or extracts thereof; and, to methods to restore energetic balance or intensity, or to support or enhance a bioenergetic field in a mammal using Shila~it or extracts thereof.
0 RA~K~.ROUND OF THE INVENTION
Over the past 50 years or so, scientists have become increasingly aware of biomagnetic energy which involves the electromagnetic energy generated by living cells, as well as subtle energetic fields, which interpenetrate and surround living organisms.(See for example Becker, R., and G. Sheldon, The Body Electric:
Electromagnetism and the Foundation of Life, New York.
William Morrow and Cl ~ny Inc., 1985; H.S. Burr and C.T.
Lane, in "Electrical Characteristics of Living Systems"
((1935) Yale Journal of Biology and Nedicine 8:31; H.S.
Burr and F.S. Northrop,"Evidence for the Existence of an Electrodynamic Field in Living Organisms" in Proceedings of the National Academy of Sciences of the U.S.A.
5:284;and,H.S. Burr, in "The Me~n;ng of Bio-Electric Potentials" ((1944) Yale Journal of Biology and Nedicine 16:353)-Vibrational medicine treats the human body byintegrating and b~lancing the energetic systems which influence cellular patterns of manifestation. The basis for vibrational medicine is the finding that a series of interactin~ subtle energy systems help regulate cellular physiology. According to the theory of vibrational medicine, a person's body tends to resonate with one ~ in~nt energetic vibration and, when weakened or shifted from equilibrium, the body tends to oscillate at a different and less harmonious frequency. These imbalances 2(~57~63 can lead to dysfunction, and the restoration of balance assists the organism to regain its normal functioning.
Anything which helps the body rebalance and/or restore the intensity of its energy can thu8 have a positive effect on health.
Acupuncture, acupressure, andelectroacupressure are examples of therapies which help to restore energetic balance. The techniques rely on influencing and balancing patterns of energy which express through meridians, or microtubular ch~nnels, which carry subtle energy to the various organs and tissues of the body. In the 1960's, Kim Bong Han discovered these microtubular chAnn~ls, ranging in diameter from 0.5 to 1.5 microns, using microautoradiography (S. Rose-Neil, "The Work of Professor Kim Bong Han", (1967) The Acupuncturist 1:15).
Other therapies which have been used to restore energetic balance and/or energetic intensity include magnetotherapy, ultrasonic therapy and homeopathy. Each of these techniques works by precipitating change in energy fields, which in turn stimulates change at the physical level. In homeopathy, a person ingests an extremely dilute solution of a substance, often so dilute that no molecules of the original substance ~F ~in. It appears that the energetic frequency of the substance, serves as the active part of the homeopathic remedy.
In the Eastern world, a compound known as Shilajit (silajit) has a history of use as a folk remedy for various disorders, including genito-urinary diseases, diabetes, gall stones, jaundice, enlarged spleen, fermentative dyspepsia, worms, digestive disorders, piles, epilepsy, nervous disorders, eczema, anaemia, anorexia, asthma etc. Shilajit has also been used as a tonic to help retain youthful vigour. Shilajit has been al' i n i stered either by itself or in combination with certain other ayurvedic (herbal) medicines.
Shilajit is a natural exudate ejected from rocks during hot weather in the lower Himalayas, Vindhya and 2~S7'~63 other mountain tracts and Nepal, or it may be a tar formed in the earth from the decomposition of vegetable substances. ~See the In~1~n Nateria Medica, page~ 23 to 32 for a detailed discussion of the compo~ition and properties of Shilajit). It is a compact ma~s of vegetable organic matter, composed of a gummy matrix interspersed with vegetable fibres and mineralq.
Substances which have been identified in Shilajit include moisture, gums, albuminoids, calcium, potassium, nitrogen, silica, resin, vegetable matter, magnesium, sulphur, iron, chloride, phosphorous, iodine, glycosides, tannic acid, and a A ~r of vitamins and enzymes. Shilajit also contains benzoic acid, a compound which, along with its derivatives, has been used as a component of nutritional vitamin and mineral preparations.
~RY OF THE INV~NTION
The present inventor has found that Shilajit over and above its nutritional and herbAl content has novel energetic properties. Measurement of subtle energy changes indicate that Shilajit has a vibratory field that is substantially stronger than any vitamin, mineral, food substance or herb. Its vibratory field is also stronger than the vibratory fields of any of the known ingredients which make up Shilajit, when these ingredients are tested as pure substances from non-Shilajit sources.
The present inventor has also surprisingly found that when a small amount of Shilajit is added to a vitamin or mineral preparation, the energetic properties of the vitamin or mineral preparation are enhAnced. In particular, the present inventor has found that the addition of a small amount of Shilajit to a vitamin or mineral preparation increases the energy field of the entire preparation to at or near the vibratory level of pure Shilajit.
The addition of Shilajit to vitamin or mineral preparations imparts to the preparations an energetic quality a~ove and beyond their nutritional content. As ;2C~S7~63 well, the energetic quality of Shilajit-fortified vitamin and mineral preparations support or enhAncc a user~s bioenergetic field.
The present invention therfore relates to the use of Shilajit or extracts thereof in a vitamin and/or mineral preparation to enhance the energy properties of the preparation.
The invention also relates to a composition comprising Shila;it or extracts thereof in a vitamin and/or mineral preparation.
The invention further relates to a method to restore energetic balance or intensity, or to support or enhance a bioenergetic field in a - ~l comprising administering to a - ~l an effective amount of Shilajit or extracts thereof. Preferably, the Shilajit or extract thereof is administered in a vitamin and/or mineral preparation.
BRIEF n~.~rRTPTION OF THE DRAWINGS
Further details of the invention are described below with the help of the examples illustrated in the accompanying drawings in which:
Figure 1 is a gragh showing the transmission of infrared light by the Original Formula vitamin- ;neral formulation;
Figure 2 is a gragh showing the transmission of infrared light by a sample containing the components of the Original Formula vitamin-mineral formulation and 13 mg of Shilajit;
Figure 3 is a gragh showing the transmission of infrared light by the Formula S.T.R. vitamin in~ral formulation;
Figure 4 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula S.T.R. vitamin-mineral formulation and 13 mg of Shilajit;
Figure 5 is a gragh showing the transmission of infrared light by a sample containing the components of ;~C~5~7~63 the Formula SnT~R~ vitamin-mineral formulation and 40 mg of Shilajit;
Figure 6 i9 a gragh showing the transmission of infrared light by the Formula SUPER C-M-K vitamin-mineral formulation;
Figure 7 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula SUPER C-M-K vitamin-mineral formulation and 13 mg of Shilajit;
Figure 8 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula SUPER C-M-K vitamin-mineral formulation and 40 mg of Shilajit;
Figure 9 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula C.N.R. vitamin-mineral formulation and by a sample containing the components of the Formula C.N.R.
vitamin-mineral formulation and 13 mg of Shilajit;
Figure 10 is a gragh showing the transmission of infrared light by a sample containing the components of the Formula V.S.C. vitamin-mineral formulation and by a sample cont~; n i ng the components of the Formula V.S.C.
vitamin-mineral formulation and 13 mg of Shilajit;
Figure 11 are chromatograms of alcohol solutions of the components of the Formula S.T.R. vitamin- ineral formulation with (Figure llA~ and without ~Figure llB) Shilajit;
Figure 12 are chromatograms of alcohol solution~
of the components of the Original Formula vitamin-mineral formulation with (Figure 12A) and without (Figure 12B) Shilajit;
Figure 13 are chromatograms of alcohol solutions of the components of the Formula C.N.R. vitamin-mineral formulation with (Figure 13A) and without (Figure 13B) Shilajit;
- Figure 14 are chromatograms of alcohol solutions of the components of the Formula S~PER C-M-K vitamin-ZC'57~63 mineral formulation with (Figure 14A) and without(Figure l~B) Shilajit;
Figure 15 are chromatographs of alcohol solutionq of the c~ ents of the Formula V.S.C. vitamin-mineral formulation with (Figure 15A) and without(Figure 15B) Shilajit.
~R~TT.Rn ~SCRTPTION OF THE INVENTION
As hereinbefore mentioned, the present invention relates to the use of Shilajit or extracts thereof in a vitamin and/or mineral preparation to enhAn~e the energy properties of the preparation. The invention also relates to a composition comprising Shilajit or extracts thereof in a vitamin and/or mineral preparation.
The vitamin and/or mineral preparation used in the invention and composition of the invention may be any commonly used vitamin and/or mineral preparation. The ingredients of an exemplary cl- -nly used vitamin and/or mineral preparation are set forth in Table 1. It will be appreciated that a vitamin and/or mineral preparation which may be used in the present invention may not include all the ingredients set forth in Table 1 and ingredients other than those set forth in Table 1 may be included in the preparation. Preferably, the vitamin and/or mineral preparation has the components set forth in any one of Tables 2 to 6. The concentration of the vitamin and/or mineral c onents will depend on individual needs and on the desired effect. Concentrations of components which may be used in the vitamin and/or mineral preparation are set forth in Tables 2 to 6.
The Shilajit used in the invention and in the composition of the invention may be obt~ined as an exudate from rocks in the Himalayas. The Shilajit may be obt~ined commercially, for example, from Dabur India Limited, New Delhi, India. The Shilajit may have the constituents set out in Table 7. Extracts of Shilajit may also be used in the present invention. Preferably, the Shilajit used in the invention is the Shilajit known as "Iron Shilajit~.
ZC'57/~63 Iron Shilajit is obtained by extracting raw Shilajit with purified water from the rocks from which it s~udes. The extracted Shila~it is then treated with a mixture of three herbs known as trifla, which include~ amla (emblica officinaliQ), bahera (ts i~Alia chebula), and haritaki (terminalia belerica), to L.- ve possible contaminants.
The purified Shila~it which is obtained i9 then dehydrated to l- -ve moisture. The Shila~it produced and refined by thiQ method is almost totally sterile. Laboratory analysis reveals that it has a bacterial count of only 50 colonies per gram and a yeast/fungus count of only 10 colonies per gram.
It will be appreciated that substances which have the energetic properties of Shilajit may also be used in the present invention. Such substances may be identified using the methods described in the examples herein. For example, a substance which has the energetic properties of Shila;it may be identified by dete ining the degree of oscillation of the substance using a Cameron Aurameter (See Example 1).
The concentration of Shilajit in the composition of the invention will depend on individual needs and on the desired effect. The concentration of the Shilajit in the composition of the invention may be from about 0.4% to 10%, preferably about 1% to 3%, most preferably 1% to 2%
by weight of the composition.
In a preferred embodiment of the invention, the c~ osition of the invention includes but is not limited to the c~ -~nts set out in Table 4 herein with 1% to 2%
by weight of Shila;it.
The composition of the invention may be prepared by ixing the various components of the composition using conventional methods. In particular, the various components of the composition of the invention may be mixed in powder form and/or encapsulated and/or pressed into solid form preparations such as tablets or pills.
The preferred composition of the invention may be prepared 2~57~63 according to the constituent ranges set forth herein in Table 1.
The invention also relate8 to ~nhAnced embodiments of the composition of the invention which include the composition described above contAini~g other additives. Examples of such additives are flavoring and coloring agents, lipotropic factors, amino acids, glAndlllar concentrates, bioflavanoids, phospholipids, para amino benzoic acid, sorbitol, betaine hydrochloride, N-N-dimethylglycine, herbs, pectin, cellulose, di-calcium phosphate, silica gel, stearic acid and magnesium - stearate.
The compositions of the invention are intende~
for A~' inistration to l- -n~ or Ani -ls.
The present invention also contemplates a method to restore energetic ~AlAnce or intensity, or to support or ~nhAn~e a bioenergetic field in a mammal comprising administering to a - -l an effective amount of Shilajit.
Preferably the method is carried out through the use of the composition described above. The method of the invention may be used to restore energy balance or energy intensity or to support or enhance a bioenergetic field in a - -l particularly in cases where there has beèn energy dysfunction as a result of disease or trauma. The compositions of the invention may be pa_ticularly useful in conditions such as artherosclerosis, heart disease, physiological stress, hypoglycemia, adrenal weAkness, arthritis, candidiasis, cancer, p~- -n~trual syndrome, menopause, prostatitis, bacterial and viral infections, heavy metal accumulations, nicotine addiction, hypertension, muscle cramping, osteoporosis, hypothyroidism, nervous tension, anaemia and cataracts.
The following non-limiting examples are illustrative of the present invention:
EXAMPL~S
r le l The energetic properties of Shilaiit-cont~ining g Z~57~63 vitamin/mineral compounds were measured using a Cameron Aurameter. The instrument is a dowsing device developed by the Life Underst~n~lng Foundation of Santa pArhAra~
California. It consists of a metallic, weighted, spring-mounted pendulum connected to a handle by means of avertically hinged mount. The unique mount enables the pendulum to oscillate either vertically or horizontally in a free-floating fashion.
The Cameron Aurameter i8 sensitive to subtle energy fields given off by both animate and in~ni -te objects. The instrument is operated as follows. The aurometer is held so that the pendulum is at complete rest. The device is then moved over the object to be tested. If sufficient energy is being given off by the object, the pendulum oscillates. The amplitude of the oscillation is directly proportional to the intensity of energy. In other words, the greater the distance taken by the pendulum in completing its stroke, the stronger the energy emanating from the object.
Five vitamin in~ral formulations distributed by Creative Nutrition CanA~ Corp. Uxbridge, Ontario, under the trade mark VITAMOST~ were tested using the above described method: FORM~ V.S.C. (Table 2), FORMULA
S.T.R. (Table 3), ORIGINAL FORMULA (Table 4), FORMULA
C.N.R. (Table 5) and S~PER C-M-K (Table 6). The composition of these vitamin-mineral formulations are - shown in Tables 2 - 6, as indicated. For each of the products, tablets with the same manufacturing lot n ~er were taken, and ground into a powder. The powders were divided into three batches and varying predeterr;ned amounts of purified Shilajit powder ( 13 mg, 40 mg or 100 mg of Shilajit (Dabur India Limited, New Delhi, India) per tablet) were added to each batch. The powders were then repressed into tablets, in such a way that each retaine~
all of its original i~gredients in the same quantities plus 13 mg of Shilajit, 40 mg of Shilajit, or 100 mg of Shilajit per tablet. As controls, samples of each formula, - lo- 2~57~63 from the same manufacturing lot number as thosc ground and mixed with Shilajit, were retained and re-tabletted.
Thus, four samples of each fo_ IAtion were obtained for testing purposes, each sample containing identical amounts of the same active ingredients ~vitamin~ and minerals), with the exception that one sample contained no Shilajit;
the second sample contained 13 mg per tablet of Shllajlt;
the third sample contained 40 mg per tablet of Shilajit;
and the fourth sample contained 100 mg per tablet of Shilajit.
The results of testing of each of the four samples of the five formulations with the Cameron Aurometer are shown in Table 8.
As shown in Table 8, the addition of small amounts of purified Shila;it powder to vitamin inpra tablets enhances the energetic properties of the tablets.
It was also found that 10 grams of purified Shilajit powder caused the Aurometer to oscillate with an amplitude of 5 centimetres. Thus, the evidence suggests that the energy field of any combined vitamin-mineral-Shilajit tablet is stronger than either (a) the energy field of the equivalent vitamin-mineral tablet without Shilajit, or (b) the energy field of Shilajit itself.
Fxample 2 The energetic response of subjects to Shilajit-cont~inin~ compounds was measured using a Colight Body Ratio Analyzing Instrument, supplied by the Electro-Nedica Office, Rexdale, Ontario. The instrument is an electronic resonance device which measures subtle energetic frequency characteristics of the human body. It consists of a series of potentiometers connected to the subject by means of a galvanic plate held against the skin.
In particular, the energetic response of five healthy subjects to each of the five different formulations shown in Tables 2 - 6 was measured. The subjects chosen were as follows: #l - Male, aged 47; #2 -Female, aged 47; #3 - Male, aged 37; #4 -Nale, aged 54;and 2C~57~63 #5 - Male, aged 25. The subjects were a ln~stered the four samples (contAining no Shilajit, 13 mg, 40 mg, or 100 mg of Shilajit per tablet) of each of the five formulations as described in Example 1. Each set of tablets was enclosed in a thin, opaque paper envelope, blinded from both the subject and the Colight operator.
Although the Colight -chine is capable of measuring the electronic resonance of many bodily cells, organs and systems, only the vitality of each subject being tested was measured. Vitality is an indication of the strength of biomagnetic energy expressed throughout the entire body. The vitality ratio for each subject was recorded at baseline, i.e. prior to ~t inistration of the samples. Each of the four samples of the five fo lAtions were then placed against the skin of the -subject and the vitality ratio of the subject was recorded for each of the twenty different samples. This allowed a ; measurement of how the energy field of the subject would respond to the energy field of the various tablets.
The results are shown in Table 9. The vitality ratio, as measured by the Colight instrument, has a no -l rang~ of from 60 to 85, according to literature published by the Electro Medica Office. The results in Table 9 sho~w that the various samples of the vitamin- ineral formulations without Shilajit increased the vitality re~ings of the subjects, on average, by 2.0~. In every case, the samples of the vitamin-mineral formulations with Shilajit increased the vitality reading of each subject beyond that of the vitality readings of the same sample fo l~tions without Shilajit. Finally, the various samples of vitamin in~ral formulations with Shilajit increased the vitality readings of the subje_ts, on average, by 10.6%.
The vitality or strength of biomagnetic energy of the tablets themselves without reference to the energy field of any person was also measured using the Colight Body Ratio Analyzing Instrument and the results are shown 2~57~63 in Table 10. As shown in Table 10 no detectable vitality was measured by this method in any of the vitamin- ineral formulations that do not contain Shilajit. Adding Shilajit to these formulations gives them a vit21ity reading at or near that of pure Shilajit itself. The vitality reAd~ngs of the enhanced formulations are approximately the -~ame, regardless of how much Shilajit is added to each formulation.
r le 3 The refractive index of Shilajit-cont~in;ng preparations was measured using an Abbé Refractometer, Type I, manufactured by Atago. The refractive index of a substance is the ratio of the velocity of light in air to the velocity of light in the substance. All measurements were taken at 24 degrees Celsius. At this temperature, the refractive index for water is 1.3326 and 1.3624 for alcohol.
The purpose of this test was to dete inP
whether Shilajit improved the ability of an alcohol solution of a vitamin-mineral composition to transmit light. The refractive index of an alcohol solution of each of the five formulations set out in Tables 2 to 6 without Shilajit was measured, and compared with the refractive index of alcohol solutions of FORMULA C.N.R.
(Table 5) with 13 mg of Shilajit; FORMULA V.S.C. (Table 2) with 40 mg of Shilajit; SUPER C-N-K (Table ~) with 40 mg of Shilajit; FORNULA S.T.R. (Table 3) with 40 mg of Shilajit; and, ORIGINAL FORMULA (Table 4) with 40 mg of Shila;it.
To prepare the alcohol solutions ten tablets of each of the formulations to be tested were crushed and two grams of each of the resultant powders were taken and extracted with isopropyl alcohol to make a 10~ solution.
The results are shown in Table 11. In every case, Shilajit lowered the refractive index of the vitamin-mineral formulation. In other words, the addition of Shilajit improved the ability of the alcohol solution 2C~S~7~;3 of each of the vitamin-mineral formulation~ to tran~mit light.
Example 4 The effect of Shilajit on the transmi~sion of infrared light by a vitamin-mineral formulation was measured using an Infrared Spectrophotometer. This instrument produces a visual graph of varying percentages of transmission at different wave lengths of infrared light.
Ten percent alcohol solutions of each of the formulations to be tested were prepared as described in Example 3 and their ability to transmit infrared light was measured using a Perkin-Elmer 1310 Infrared spectrophotome~er. The results are shown in Figures 1 to 10. Because the machine may start at a different setting for each printout, the graphs are a relative or comparative form of measurement, rather than an absolute one. Therefore, when comparing the graphs for two different samples of the same formula, the shape of the curves is significant but the absolute measurement on the left-hand scale is not. For the same reason, the absolute numbers on the left-hand scale are not significant when comparing two readings on different curves, whereas the difference between two readings on the same curve are significant.
In comparing the graphs for the ORIGINAL
FORMULA, more peaks reached far higher for the formulation containing 13 mg of Shilajit per tablet (Figure 2) than for the one with no Shilajit (Figure 1). The latter curve (Figure 1) is very flat, with low plateaus rather than peaks. Similar relationships were found when comparing S.T.R. with 13 (Figure 4) and 40 mg (Figure 5) of Shilajit, whose curves show very high peaks, to S.T.R.
without Shilajit (Figure 3), which is very flat with low plateaus.
The curves for SUPER C.M.K. with 40 (Figure 7) and 13 mg (Figure 8) of Shilajit are almost identical~
2(!St~63 with high peaks, in the range of 4,000 to 1,600 cm~1, compared to the curve for SUPER C.M.K. without Shilajit (Figure 6) over the same range, which i8 almost completely flat.
Samples of Formula C.N.R. with and without Shilajit and samples of Formula V.S.C. with and without Shilajit were run simultaneously. The results of the C.N.R. without Shilajit and with 13 mg of Shilajit are shown in Figure 9 and the results of the V.S.C. without Shilajit and with 13 mg of Shilajit are shown in Figure 10. In both cases, the samples of the formulations with 13 mg of Shilajit were found to transmit about 10% more infrared light over the range of 3500 to 2700 cm~1 when compared to the samples without Shilajit, and approximately 2~ more in the ranges from 2700 to 2300 cm~
and from 1150 to 1000 cm~1.
The results indicate that the addition of Shilajit to otherwise identical vitamin-mineral formulations was found to improve the ability of these formulations to transmit infrared light.
Example 5 Paper chromatography was used to analyze samples of the vitamin/mineral formulations set out in Tables 1 to 5 with or without Shilajit. Paper chromatography is a qualitative method used for separating and identifying mixtures of substances, including vitamins and food products. The method i5 useful for discerning subtle differences in vitamins and food samples produced by different processing methods or from different soil conditions -- differences which are not detectable by quantitative assay.
The method described in Pfeiffer, E.E.
Chromatography Applied to Quality Testing, Wyoming:
Biodynamic Literature, 1984 was used to analyze samples of the vitamin/mineral formulations set out in Tables 2 to 6 with or without Shilajit. The method generally involves preparing a filter disk with a 0.1% silver nitrate ~c\s~
_ 15 -solution, and impregnating the prepared disk with a liquid extract of the test sample in a 0.1~ sodium hydroxide solution. This method results in the formation of various colour zones and patterns which reflect certaln aspects of sample quality.
Nuch work has been done with paper chromatography in comparing synthetic vitamins to natural source vitamins, and in comparing organic produce to that produced by conventional agricultural methods. (Pfeiffer, Ibid.) In both of these kinds of comparisons, the natural/organic versions display colours and patterns which are more distinct, deeper and more vibrant than their synthetic or conventional counterparts. Also, there are more pronounced boundaries and more clearly de~ined radial spokes in the natural/organic substances.
Chromatograms of samples containing each of Formula STR, ORGINAL, CNR, CMK and VSC without Shilajit and with Shilajit are shown in Figures 11 to 15. As shown in Figures 11 to 15 the samples with Shilajit (Figures llA, 12A, 13A, 14A and 15A) produce colour images which are more vibrant, more distinct, and with more clearly defined borders and more obvious radial spokes than the samples without Shilajit (Figures llB, 12B, 13B, 14B and 15B). These qualitative differences suggest an enh~n~ed energy quality for the samples with Shilajit compared to those without.
In particular, the presence of the vitamins and minerals in Formula S.T.R. give the paper disk its characteristic colours of reddish-brown, green, yellow and brown (going from the centre to the perimeter) (Figure llB). In the enh~nced Shila~it version, however, the rings of colour are deeper, more clearly defined and more vibrant (Figure llA). There is an extra ring of a deep blue (almost cobalt blue) in the Shilajit enh~nced formula that is not in the STR without Shilajit. The outside brown border is wider in the Shilajit version.
There is also an obvious spoke pattern interspersed with - 16 - ~C's~63 glimpses of the very light yellow (almost white) colour that does not appear in the STR without Shilajit.
The Shilajit enhanced verslon of the Original formula (Figure 12A) di4plays a distinct pattern of colours, spokes and rings that are quite different from the version without Shilajit (Figure 12B).
The differences between the two samples of the C.N.R. formula are more subtle, but they exist nevertheless. The outermost brown border is darker and more distinct for the version with Shilajit (Figure 13A).
There is a thin, brown ring about one quarter inch inside the perimeter in the version with Shilajit which is not apparent in the version without Shilajit (Figure 13B).
~ Also, the green colour and its fine spoke pattern is more - 15 distinct in the version with Shilajit.
The colour of the original paper disk for the Super C-M-K without Shilajit is a whitish gray (Figure 14B). This is so because the only active ingredients in this formula are calcium, magnesium and potassium. There are no vitamins present that would contribute the spectrum of colours visible in the other formulations. The ~nh~nced C-M-K with Shilajit, however, has a more distinct yellow perimeter than the C-M-R
without Shilajit (Figure 14A). The enh~nced Shilajit sample also has an obvious and distinct brown border (inside the outer yellowish one) which is almost totally lacking in the sample without Shilajit. The centre of the Shilajit enhanced sample contains a bluish-brown stain that is several times larger and many times more distinct than a very faint hint of such a stain in the sample without Shilajit.
The boarders of the colours in the Shilajit enh~nced sample of the V.S.C. formula are more clear and distinct (Figure 15A) than in the version without Shilajit (Figure 15B). In this latter version, the colours saem to wander or spill over from one ring to the next.
- 17 - 2C'5~7~63 TABL~ 1 Each Tablet contains Vitamin A . . . . . . . . . . . . 500 to 10,000 I.U.
Beta Carotene . . . . . . . . . 2,000 to 15,000 I.U.
Vitamin D . . . . . . . . . . . . . . 50 to 400 I.U.
Vitamin E . . . . . . . . . . . . . . 30 to 400 I.U.
Vitamin C . . . . . . . . . . . . . . 75 to l,000 mg Vitamin B-l . . . . . . . . . . . . . . . 2 to 80 mg Vitamin B-2 . . . . . . . . . . . . . . . 1 to 80 mg Niacin . . . . . . . . . . . . . . . . . 4 to 100 mg Niacinamide . . . . . . . . . . . . . . . 2 to 100 mg Pantothenic Acid . . . . . . . . . . . . 10 to 500 mg Vitamin B-6 . . . . . . . . . . . . . . 3 to 100 mg Folic Acid . . . . . . . . . . . . . 0.002 to 1 mg 15 Vitamin B-12 . . . . . . . . . . . . 3 to l,000 mcg Biotin . . . . . . . . . . . . . . . . . 3 to 80 mcg Calcium . . . . . . . . . . . . . . . . . 40 to 200 mg Nagnesium . . . . . . . . . . . . . . . 30 to 200 mg Potassium . . . . . . . . . . . . . . . 10 to 200 mg Iron . . . . . . . . . . . . . . . . . . 1 to 25 mg Iodine . . . . . . . . . . . . . . . 0.02 to 0.5 mg Manganese . . . . . . . . . . . . . . . . 0.8 to 6 mg Zinc . . . . . . . . . . . . . . . . . 1.5 to 30 mg Chromium . . . . . . . . . . . . . . . 10 to 80 mcg Selenium . . . . . . . . . . . . . . . 20 to 50 mcg 2C~57~63 VITAMOST~ Fr l~ V.S.C.
Vitamins Each Tablet contains 5 Vitamin A (fish liver oil) . . . . . . . 2,000 I.U.
Beta Carotene (pro-vitamin A) . . . . 6,000 I.U.
Vitamin E 'd-alpha tocopheryl succ.) . . . . 60 I.U.
Vitamin C calcium ascorbate) . . . . . . . . 150 mg Vitamin C ascorbic acid) . . . . . . . . . . 350 mg Vitamin B-_ (th;~ ine hydrochloride) . . . . . . 2 mg Vitamin B-2 (riboflavin) . . . . . . . . . . . . 1 mg Vitamin B-6 (pyridoxine hydrochloride) . . . . . 3 mg Vitamin B-12 (cobalamin) . . . . . . . . . . . 3 mcg Niacin ............................................ 4 mg 15 Niacinamide ....................................... 2 mg Pantothenic Acid (d-calc. pantothen.) . . . . . . 2 mg Folic Acid . . . . . . . . . . . . . . . . . 0.03 mg Biotin ............................................ 3 mcg LipoLlv~ic Factors Choline (bitartrate) . . . . . . . . . . . . . 40 mg Inositol .......................................... 10 mg dl-Methionine . . . . . . . . . . . . . . . . . 100 mg Minerals Magnesium toxide) . . . . . . . . . . . . . . . 30 mg 25 Potassium (citrate~ . . . . . . . . . . . . . . 10 mg Manganese (gluconate) . . . . . . . . . . . . . 1 mg Zinc (gluconate) . . . . . . . . . . . . . . . 1.5 mg Chromium (proteinate) . . . . . . . . . . . . . 20 mcg Selenium (proteinate) . . . . . . . . . . . . . 20 mcg 30 ~~ Medicinal Ingredients Betaine Hydrochloride . . . . . . . . . . . . . 12 mg Lemon Bioflavanoids . . . . . . . . . . . . . . 15 mg 1-Cysteine Hydrochloride . . . . . . . . . . . 75 mg Lecithin . . . . . . . . . . . . . . . . . . . 10 mg 35 ihy ~ concentrate ................................. 3 mg Spleen concentrate ................................ 3 mg Adrenal concentrate ............................... 3 mg ;~C'~i~7~i3 TAHL~ 3 VITANOSTo Fn 1 A S.T.R.
Vitamins Each Tablet contains Vitamin A 'fish liver oil) . . . . . . . . 2,500 I.U.
Vitamin D fish liver oil) . . . . . . . . . 100 I.U.
Vitamin E d-alpha tocopheryl succinate) . . 40 I.U.
Vitamin C ascorbic acid) . . . . . . . . . . . 200 mg Vitamin B-_ ( t,h;, ine hydrochloride ? . . . . . . 5 mg Vitamin B-2 (riboflavin) . . . . . . . . . . . . 5 mg 10 Vitamin B-6 (pyridoxine hydrochloride) . . . . 10 mg Vitamin B-12 (cobalamin) . . . . . . . . . . . 50 mcg Niacinamide .......................................... 5 mg Pantothenic Acid (d-calcium pantothenate) . . . 150 mg Folic Acid . . . . . . . . . . . . . . . . . 0.04 mg 15 Biotin . . . . . . . . . . . . . . . . . . . . 10 mcg Li~o~o~ic Factors Choline (bitartrate) . . . . . . . . . . . . . 10 mg Inositol . . . . . . . . . . . . . . . . . . . 10 mg Minerals 20 Calcium (carbonate) . . . . . . . . . . . . . . 50 mg Magnesium (oxide) . . . . . . . . . . . . . . . 35 mg Potassium (chloride) . . . . . . . . . . . . . 40 mg Iron (ferrous fumarate) . . . . . . . . . . . . 1.5 mg Iodine (potassium iodide) . . . . . . . . . 0.0225 mg Manganese (gluconate) . . . . . . . . . . . . . . 2 mg Zinc (gluconate) . . . . . . . . . . . . . . . 1.5 mg Chromium (proteinate) . . . . . . . . . . . . . 20 mcg Selenium (proteinate) . . . . . . . . . . . . . 20 mcg ~on-Medicinal Ingredients Para Amino Benzoic Acid (P.A.B.A) . . . . . . . . 5 mg B0taine Hydrochloride . . . . . . . . . . . . . 15 mg Lemon Bioflavanoids . . . . . . . . . . . . . . 20 mg Adrenal concentrate . . . . . . . . . . . . . . 10 mg 2~5~f~63 TABL~ 4 VITANOST~ Original F~ 1 A
Vitamins Each Tablet contains Vitamin A 'fish liver oil) . . . . . . . . 4,167 I.U.
Vitamin D fish liver oil) . . . . . . . . . 167 I.U.
Vitamin E d-alpha tocopheryl succinate) . 66.7 I.U.
Vitamin C ascorbic acid) . . . . . . . . . . . 200 mg Vitamin B- (thi~ ine hydrochloride) . . . . . 10 mg Vitamin B-2 (riboflavin) . . . . . . . . . . . 10 mg Vitamin B-6 (pyridoxine hydrochloride) . . . . . 10 mg Vitamin B-12 (cobalamin) . . . . . . . . . . 16.7 mcg Niacin~ i~e . . . . . . . . . . . . . . . . . . 10 mg Pantothenic Acid (d-calcium pantothenate) . . . 20 mg Folic Acid . . . . . . . . . . . . . . . . . 0.067 mg Biotin . . . . . . . . . . . . . . . . . . . 16.7 mcg Li~oLl~ic Factors Choline (bitartrate) . . . . . . . . . . . . . 10 mg Inositol . . . . . . . . . . . . . . . . . . . 10 mg Minerals Calcium (carbonate) . . . . . . . . . . . . . . 167 mg Magnesium (oxide) . . . . . . . . . . . . . . 66.7 mg Potassium (chloride) . . . . . . . . . . . . 16.5 mg Iron (ferrous fumarate) . . . . . . . . . . . . . 3 mg Iodine (potassium iodide) . . . . . . . . . . 0.038 mg Manganese (gluconate) . . . . . . . . . . . . . . 3 mg Zinc (glucona~e) . . . . . . . . . . . . . . . . 3 mg Chromium (proteinate) . . . . . . . . . . . . 33.3 mcg Selenium (proteinate) . . . . . . . . . . . . . 25 mcg ~ F A i C i n~ 1 Ingredients Para Amino Benzoic Acid (P.A.B.A) . . . . . . . 10 mg Betaine Hydrochloride . . . . . . . . . . . . . 20 mg Lemon Bioflavanoids . . . . . . . . . . . . . . 20 mg - 21 - 2C'5'7~3 VITAMOST~ F~ 1~ C.N.R.
Vitamins Each Tablet contains Beta Carotene (pro-vitamin A) . . . . . . 15,000 I.U.
Vitamin C (calcium ascorbate) . . . . . . . . . 835 mg Lipotropic Factors dl-Methionine ................................ 5 mg Nineral Selenium (proteinate) . . . . . . . . . . . . . 25 mcg 0 T-~ ~ FAiCin~1 Ingredients Glutathione . . . . . . . . . . . . . . . . . . 1.3 mg N,N-Dimethylglycine . . . . . . . . . . . . . . . 8 mg In a non-medicinal base containing Echinacea, Red Clover, Liver concentrate, Thymus concentrate, Damiana, Burdock, Marshmallow, Spleen concentrate, Elecampagne and Buckthorn.
The product contains no sugar, no starch, no colourings, no flavourings, no preservatives, no milk, no wheat, no corn, no gluten, no soy, no yeast.
- 22 - ~C'57~63 VITAMOST~ Super C-M-R
Vitamins Each Tablet contains Calcium (carbonate) . . . . . . . . . . . . . . 200 mg Nagnesium (oxide) . . . . . . . . . . . . . . . 200 mg Potassium (chloride) . . . . . . . . . . . . . 200 mg The product contains no sugar, no starch, no colourings, no flavourings, no preservatives, no milk, no gluten, no corn, no soy, and no yeast.
- 23 - ;~C'57~63 C _ nition of Shila~it~
~ - L
Organic (per cent) Benzoic acid 28 58 Hippuric acid 6.13 Fatty acids 2.36 Resin and waxy matter 7 32 10 Gums 1 .
Albuminoids 16.12 Vegetable matter, sand, etc. 2.15 Minerals**
Loss on ignition 5182.33 Silica (residue insoluble in HCl)2 69 Iron (Fe2~3) 0.64 Alumina (Al2O3) 2.61 Lime (CaO) 4.82 20 Magnesia (MgO) 1.20 - Sulphuric acid (S03) 0 97 Chloride (NaCl) oo 524 Phosphoric acid (P2O5) 25 Nitrogen 3.36 * From the Indian Nateria Nedica, pages 25 and 26.
**Mineral constituents obtained from the ash by incineration of the substance at a dull red heat.
- 24 - Z~57~63 Shila~it/ No. oi Au~ -Ler P O~U1 L Tablet Tablets Stroke SUPER C-M-K 0 4 3 cm 5 SUPER C-M-K 13 mg 4 7 cm SUPER C-M-K 40 mg 4 7 cm SUPER C-M-K 100 mg 4 7 cm FORMULA C.N.R. 0 12 3 cm FORNULA C.N.R. 13 mg 12 6 cm 10 FORMULA C.N.R. 40 mg 12 6 cm FORMULA C.N.R. 100 12 6 cm ORIGINAL FORMULA 0 6 3 cm ORIGINAL FORMULA 13 mg 6 7 cm ORIGINAL FORNULA 40 mg 6 7 cm 15 ORIGINAL FORMULA 100 mg 6 6 cm FORNULA S.T.R. 0 10 4 cm FORMULA S.T.R. 13 mg 10 6 cm FORMULA S.T.R. 40 mg 10 6 cm FORMULA S.T.R. 100 mg 10 6 cm 20 FORMULA V.S.C. 0 10 4 cm FORMULA V.S.C. 13 mg 10 7 cm FORMULA V.S.C. 40 mg 10 8 cm FORMUhA V.S.C. 100 mg 10 7 cm - 25 - 2C'57~;3 Subiect ~ t4 Baseline 63 66 72 80 74 Formula V.S.C. without Shilajit 67 68 73 82 75 Formula V.S.C. with 13 mg Shilajit 77 81 78 86 77 Formula V.S.C. with 40 mq Shilajit 81 81 82 86 77 Formula V.S.C. with 100 mg Shilajit 73 74 79 83 80 Baseline 63 66 72 80 74 10 Formula S.T.R. without Shilajit 65 69 73 80 75 Formula S.T.R. with 13 mg Shilajit 80 75 76 81 76 Formula S.T.R. with 40 mg Shilajit 73 83 85 81 77 Formula S.T.R. with 100 mg Shilajit 78 74 75 84 81 Baseline 63 66 72 80 74 15 Original Formula without Shilajit 64 67 73 81 74 Originial Formula with 13 mg Shilajit 71 72 74 87 79 Originial Formula with 40 mg Shilajit 71 80 78 84 79 Originial Formula with 100 mg Shilajit 72 77 75 90 78 Baseline 63 66 72 80 74 20 Formula C.N.R. without Shilajit 64 68 78 80 74 Formula C.N.R. with 13 mg Shilajit 75 75 85 82 77 Formula C.N.R. with 40 mg Shilajit 81 78 85 84 81 Formula C.N.R. with 100 mg Shilajit 71 77 83 81 78 Baseline 63 66 72 80 74 25 Super C-M-X without Shilajit 63 69 72 82 75 Super C-M-K with 13 mg Shilajit 72 75 79 84 77 Super C-M-K with 40 mg Shilajit 72 74 78 83 77 Super C-M-K with 100 mg Shilajit 66 72 84 84 78 - 26 - 2C~S7~6~
Vitalit~
R~Ar1; r~"~
Pure Shilajit 41 5 Formula VSC without Shilajit 0 Formula VSC with 13 mg Shilajit 41 Formula VSC with 40 mg Shilajit 43 Formula VSC with 100 mg Shilajit 41 Formula STR without Shilajit 0 10 Formula STR with 13 mg Shilajit 42 Formula STR with 40 mg Shilajit 42 Formula STR with 100 mg Shilajit 41 Original Formula without Shilajit 0 Original Formula with 13 mg Shilajit41 15 Original Formula with 40 mg Shilajit 37 Original Formula with 100 mg Shilajit41 Formula CNR without Shilajit 0 Formula CNR with 13 mg Shilajit 42 Formula CNR with 40 mg Shilajit 42 20 Formula CNR with 100 mg Shilajit 38 Super C-N-K without Shilajit 0 Super C-M-K with 13 mg Shilajit 41 Super C-N-K with 40 mg Shilajit 40 Super C-M-K with 100 mg Shilajit 40 - 27 - ;~C~S7~6~
Reiractive FORMULA C.N.R. with no Shilajit 1.3690 FORMULA C.N.R. with 13 mg of Shilajit 1.3682 FORMULA V.S.C. with no Shilajit 1.3841 FORMULA V.S.C. with 40 mg of Shilajit 1.3680 SUPER C-N-K with no Shilajit 1.3634 SUPER C-M-K with 40 mg of Shilajit 1.3624 10 FORMULA S.T.R. with no Shilajit 1.3654 FORMULA S.T.R. with 40 mg of Shilajit 1.3644 ORIGINAL FORMULA with no Shilajit 1.3664 ORIGINAL FORMULA with 40 mg of Shilajit 1.3650
Claims (12)
1. A composition comprising Shilajit or an extract thereof in a vitamin and/or mineral preparation in which the Shilajit or extract thereof is present in an amount from about 0.4 to about 10.0 per cent by weight of the total composition.
2. A composition as claimed in Claim 1 wherein the Shilajit or an extract thereof is iron Shilajit.
3. A composition as claimed in Claim 1 which is in the form of a solid formulation.
4. A composition as claimed in Claim 3 in which the Shilajit or an extract thereof is present in an amount from about 1 to about 3 per cent of the total weight of the formulation.
5. A composition as claimed in claim 1, wherein the vitamin and/or mineral preparation has the following components:
Vitamin A . . . . . . . . . 500 to 10,000 I.U.
Beta Carotene . . . . . . 2,000 to 15,000 I.U.
Vitamin D . . . . . . . . . . . 50 to 400 I.U.
Vitamin E . . . . . . . . . . . 30 to 400 I.U.
Vitamin C . . . . . . . . . . . 75 to 1,000 mg Vitamin B-1 . . . . . . . . . . . . 2 to 80 mg Vitamin B-2 . . . . . . . . . . . . 1 to 80 mg Niacin . . . . . . . . . . . . . . 4 to 100 mg Niacinamide . . . . . . . . . . . . 2 to 100 mg Pantothenic Acid . . . . . . . . 10 to 500 mg Vitamin B-6 . . . . . . . . . . . . 3 to 100 mg Folic Acid . . . . . . . . . . . 0.002 to 1 mg Vitamin B-12 . . . . . . . . . 3 to 1,000 mcg Biotin . . . . . . . . . . . . . . 3 to 80 mcg Calcium . . . . . . . . . . . . . 40 to 200 mg Magnesium . . . . . . . . . . . . 30 to 200 mg Potassium . . . . . . . . . . . . 10 to 200 mg Iron . . . . . . . . . . . . . . . 1 to 25 mg Iodine . . . . . . . . . . . . 0.02 to 0.5 mg Manganese . . . . . . . . . . . . . 0.8 to 6 mg Zinc . . . . . . . . . . . . . . 1.5 to 30 mg Chromium . . . . . . . . . . . . 10 to 80 mcg Selenium . . . . . . . . . . . . 20 to 50 mcg
Vitamin A . . . . . . . . . 500 to 10,000 I.U.
Beta Carotene . . . . . . 2,000 to 15,000 I.U.
Vitamin D . . . . . . . . . . . 50 to 400 I.U.
Vitamin E . . . . . . . . . . . 30 to 400 I.U.
Vitamin C . . . . . . . . . . . 75 to 1,000 mg Vitamin B-1 . . . . . . . . . . . . 2 to 80 mg Vitamin B-2 . . . . . . . . . . . . 1 to 80 mg Niacin . . . . . . . . . . . . . . 4 to 100 mg Niacinamide . . . . . . . . . . . . 2 to 100 mg Pantothenic Acid . . . . . . . . 10 to 500 mg Vitamin B-6 . . . . . . . . . . . . 3 to 100 mg Folic Acid . . . . . . . . . . . 0.002 to 1 mg Vitamin B-12 . . . . . . . . . 3 to 1,000 mcg Biotin . . . . . . . . . . . . . . 3 to 80 mcg Calcium . . . . . . . . . . . . . 40 to 200 mg Magnesium . . . . . . . . . . . . 30 to 200 mg Potassium . . . . . . . . . . . . 10 to 200 mg Iron . . . . . . . . . . . . . . . 1 to 25 mg Iodine . . . . . . . . . . . . 0.02 to 0.5 mg Manganese . . . . . . . . . . . . . 0.8 to 6 mg Zinc . . . . . . . . . . . . . . 1.5 to 30 mg Chromium . . . . . . . . . . . . 10 to 80 mcg Selenium . . . . . . . . . . . . 20 to 50 mcg
6. A use of Shilajit or an extract thereof in a vitamin and/or mineral preparation, wherein the Shilajit is present in an amount from about 0.4 to about 10 per cent by weight of the vitamin and/or mineral preparation, to enhance the energy properties of the preparation.
7. A use as claimed in Claim 6 wherein the Shilajit or an extract thereof is iron Shilajit.
8. A use as claimed in Claim 6 wherein the Shilajit or an extract thereof is present in an amount from about 1 to about 3 per cent of the total weight of the vitamin and/or mineral preparation.
9. A composition as claimed in claim 1, wherein the multi vitamin and/or mineral preparation comprises Vitamin A and Vitamin C.
10. A composition as claimed in claim 1, wherein the multi vitamin and/or mineral preparation comprises Vitamin A and Vitamin C and selenium.
11. A composition as claimed in claim 1 wherein the multi vitamin and/or mineral preparation comprises Vitamin A, Vitamin D, Vitamin E, Vitamin C, Vitamin B, Niacinamide, Pantothenic Acid, Folic Acid, Calcium, Magnesium, Potassium, Manganese, Zinc, and/or Selenium.
12. A composition comprising iron Shilajit in a multi vitamin and/or mineral preparation wherein the Shilajit is present in a concentration of between 0.4 and 10.0 per cent of the total weight of the composition and the multi vitamin and/or mineral preparation comprises vitamin A, Vitamin D, Vitamin E, Vitamin C, Vitamin B, Niacinamide, Pantothenic Acid, Folic Acid, Calcium, Magnesium, Potassium, Manganese, Zinc, and/or Selenium, and wherein the composition is in the form of a solid formulation for oral administration.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2057463 CA2057463C (en) | 1991-12-11 | 1991-12-11 | Vitamin/mineral composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2057463 CA2057463C (en) | 1991-12-11 | 1991-12-11 | Vitamin/mineral composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2057463A1 CA2057463A1 (en) | 1993-06-12 |
| CA2057463C true CA2057463C (en) | 1998-10-27 |
Family
ID=4148915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2057463 Expired - Lifetime CA2057463C (en) | 1991-12-11 | 1991-12-11 | Vitamin/mineral composition |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2057463C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080855A (en) * | 1993-05-22 | 1994-01-19 | 黎均耀 | Anticarcinogenic vitamin and mineral complex prescription |
| AU1938895A (en) * | 1994-05-02 | 1995-11-29 | Abbott Laboratories | Inhibition of atherosclerosis by antioxidants |
| AU702831B2 (en) * | 1994-12-22 | 1999-03-04 | Henkel Corporation | Compositions of tocopherol and beta-carotene |
| AU2583397A (en) * | 1996-04-10 | 1997-10-29 | Chronorx, Llc | Unit dosage forms, containing magnesium, vitamin c, vitamin e, folate and selenium, for treatment of vasoconstriction and related conditions |
| EP0834319A1 (en) * | 1996-10-07 | 1998-04-08 | Kartar Dr. Lalvani | Mineral and vitamin combinations in arthritic pain |
| GB9715203D0 (en) * | 1997-07-19 | 1997-09-24 | Piper Edwina M | Composition |
| WO2006035075A1 (en) * | 2004-09-30 | 2006-04-06 | Bioxell Spa | Use of vitamin d compounds for the prevention or treatment of chronic prostatitis |
| WO2013052117A1 (en) * | 2011-10-05 | 2013-04-11 | Golini Jeffrey M | Choline composition |
| US20140271982A1 (en) * | 2013-03-15 | 2014-09-18 | Eduardo Fernandez | Gummy compositions for nutritional supplementation |
-
1991
- 1991-12-11 CA CA 2057463 patent/CA2057463C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2057463A1 (en) | 1993-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5405613A (en) | Vitamin/mineral composition | |
| Shamberger | Increase of peroxidation in carcinogenesis | |
| CA2057463C (en) | Vitamin/mineral composition | |
| Nabavi et al. | Biological activities of flavonoid-rich fraction of Eryngium caucasicum Trautv. | |
| CA2627314C (en) | Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves | |
| CN1074123A (en) | Method for preparing pharmaceutical composition for selectively reducing blood lipid level | |
| DE69005753T2 (en) | Pharmaceutical compositions with an effect on microcirculation in the skin. | |
| KR20190116837A (en) | Composition Comprising Radish Extract for Improving Skin Wrinkle and Elasticity | |
| Schultes | Plants in treating senile dementia in the Northwest Amazon | |
| EP1560561A1 (en) | METHOD FOR PROTECTION OF SKIN AGAINST SUN-INDUCED DAMAGE BY ORAL ADMINISTRATION OF AN EXTRACT OF EMBLICA OFFICINALIS (syn. PHYLLANTHUS EMBLICA) | |
| KR0164004B1 (en) | Anti-aging Health Food Composition | |
| EP1539201B1 (en) | Antipyrotic and method of manufacturing the same | |
| CN1857415A (en) | Health product for women to delay senility and its preparing process | |
| Al-Asmari et al. | Endangered Saudi Arabian plants having ethnobotanical evidence as antidotes for scorpion envenoming | |
| KR100411370B1 (en) | Ixeris Dentata extract having biological activities and immunity enhancing effects | |
| CN115349636A (en) | Whitening and spot-fading composition containing cubilose peptide and preparation method and application thereof | |
| KR102324749B1 (en) | Cosmetic Composition For Alleviating Skin Aging Comprising Helianthus Annuus Seed Oil and Carthamus Tinctorius Seed Oil | |
| KR101933152B1 (en) | Composition for improving skin condition comprising pomegranate concentrate as active ingredient | |
| KR101927826B1 (en) | Composition for improving skin condition comprising pomegranate concentrate as active ingredient | |
| CN113559037A (en) | A kind of cassia seed compound collagen liposome and its application | |
| Afshari | The chronicle of arsenic poisoning in the 19th century | |
| KR20060085249A (en) | External skin preparation | |
| KR100293736B1 (en) | Korean extracts containing sugar-binding protein and methods for producing the same | |
| CN109395008A (en) | Chinese medicine composition and its application for treating osteoporosis | |
| Lakshmi | Invitro Antihelmintic Activity of Individual and Combined Leaf Extracts (Punica granatum and Psidium guajava) Against Pheritima Posthuma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |